vs

Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and Iridium Communications Inc. (IRDM). Click either name above to swap in a different company.

Iridium Communications Inc. is the larger business by last-quarter revenue ($219.1M vs $196.0M, roughly 1.1× Axsome Therapeutics, Inc.). Iridium Communications Inc. runs the higher net margin — 9.9% vs -14.6%, a 24.4% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 1.9%). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 4.4%).

Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.

Iridium Communications Inc. is a publicly traded American company headquartered in McLean, Virginia, United States. Iridium operates the Iridium satellite constellation, a system of 80 satellites: 66 are active satellites and the remaining fourteen function as in-orbit spares. Iridium Satellites are used for worldwide voice and data communication from handheld satellite phones, satellite messenger communication devices and integrated transceivers, as well as for two-way satellite messaging se...

AXSM vs IRDM — Head-to-Head

Bigger by revenue
IRDM
IRDM
1.1× larger
IRDM
$219.1M
$196.0M
AXSM
Growing faster (revenue YoY)
AXSM
AXSM
+63.1% gap
AXSM
65.0%
1.9%
IRDM
Higher net margin
IRDM
IRDM
24.4% more per $
IRDM
9.9%
-14.6%
AXSM
Faster 2-yr revenue CAGR
AXSM
AXSM
Annualised
AXSM
61.7%
4.4%
IRDM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AXSM
AXSM
IRDM
IRDM
Revenue
$196.0M
$219.1M
Net Profit
$-28.6M
$21.6M
Gross Margin
Operating Margin
-13.8%
23.2%
Net Margin
-14.6%
9.9%
Revenue YoY
65.0%
1.9%
Net Profit YoY
61.9%
-29.0%
EPS (diluted)
$-0.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXSM
AXSM
IRDM
IRDM
Q1 26
$219.1M
Q4 25
$196.0M
$212.9M
Q3 25
$171.0M
$226.9M
Q2 25
$150.0M
$216.9M
Q1 25
$121.5M
$214.9M
Q4 24
$118.8M
$213.0M
Q3 24
$104.8M
$212.8M
Q2 24
$87.2M
$201.1M
Net Profit
AXSM
AXSM
IRDM
IRDM
Q1 26
$21.6M
Q4 25
$-28.6M
$24.9M
Q3 25
$-47.2M
$37.1M
Q2 25
$-48.0M
$22.0M
Q1 25
$-59.4M
$30.4M
Q4 24
$-74.9M
$36.3M
Q3 24
$-64.6M
$24.4M
Q2 24
$-79.3M
$32.3M
Operating Margin
AXSM
AXSM
IRDM
IRDM
Q1 26
23.2%
Q4 25
-13.8%
25.9%
Q3 25
-27.0%
30.9%
Q2 25
-24.5%
23.2%
Q1 25
-46.9%
28.1%
Q4 24
-61.1%
24.5%
Q3 24
-59.8%
25.8%
Q2 24
-89.5%
21.7%
Net Margin
AXSM
AXSM
IRDM
IRDM
Q1 26
9.9%
Q4 25
-14.6%
11.7%
Q3 25
-27.6%
16.4%
Q2 25
-32.0%
10.1%
Q1 25
-48.9%
14.2%
Q4 24
-63.1%
17.1%
Q3 24
-61.7%
11.5%
Q2 24
-91.0%
16.1%
EPS (diluted)
AXSM
AXSM
IRDM
IRDM
Q1 26
Q4 25
$-0.55
$0.24
Q3 25
$-0.94
$0.35
Q2 25
$-0.97
$0.20
Q1 25
$-1.22
$0.27
Q4 24
$-1.54
$0.30
Q3 24
$-1.34
$0.21
Q2 24
$-1.67
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXSM
AXSM
IRDM
IRDM
Cash + ST InvestmentsLiquidity on hand
$322.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$88.3M
Total Assets
$689.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXSM
AXSM
IRDM
IRDM
Q1 26
Q4 25
$322.9M
$96.5M
Q3 25
$325.3M
$88.5M
Q2 25
$303.0M
$79.3M
Q1 25
$300.9M
$50.9M
Q4 24
$315.4M
$93.5M
Q3 24
$327.3M
$159.6M
Q2 24
$315.7M
$63.5M
Total Debt
AXSM
AXSM
IRDM
IRDM
Q1 26
Q4 25
$1.8B
Q3 25
Q2 25
Q1 25
Q4 24
$1.8B
Q3 24
Q2 24
Stockholders' Equity
AXSM
AXSM
IRDM
IRDM
Q1 26
Q4 25
$88.3M
$462.6M
Q3 25
$73.7M
$450.5M
Q2 25
$73.1M
$473.6M
Q1 25
$53.2M
$518.4M
Q4 24
$57.0M
$576.6M
Q3 24
$92.9M
$663.8M
Q2 24
$102.9M
$786.7M
Total Assets
AXSM
AXSM
IRDM
IRDM
Q1 26
Q4 25
$689.8M
$2.5B
Q3 25
$669.3M
$2.6B
Q2 25
$639.8M
$2.6B
Q1 25
$596.7M
$2.6B
Q4 24
$568.5M
$2.7B
Q3 24
$561.5M
$2.8B
Q2 24
$548.2M
$2.7B
Debt / Equity
AXSM
AXSM
IRDM
IRDM
Q1 26
Q4 25
3.80×
Q3 25
Q2 25
Q1 25
Q4 24
3.05×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXSM
AXSM
IRDM
IRDM
Operating Cash FlowLast quarter
$-18.7M
Free Cash FlowOCF − Capex
$-18.7M
FCF MarginFCF / Revenue
-9.6%
Capex IntensityCapex / Revenue
0.0%
13.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXSM
AXSM
IRDM
IRDM
Q1 26
Q4 25
$-18.7M
$108.6M
Q3 25
$1.0M
$100.8M
Q2 25
$-32.4M
$129.6M
Q1 25
$-43.4M
$61.1M
Q4 24
$-26.2M
$104.8M
Q3 24
$-18.6M
$118.6M
Q2 24
$-30.1M
$81.1M
Free Cash Flow
AXSM
AXSM
IRDM
IRDM
Q1 26
Q4 25
$-18.7M
$75.1M
Q3 25
$988.0K
$79.2M
Q2 25
$-32.4M
$108.9M
Q1 25
$-43.7M
$36.5M
Q4 24
$-26.2M
$80.5M
Q3 24
$-18.7M
$100.0M
Q2 24
$-30.2M
$68.7M
FCF Margin
AXSM
AXSM
IRDM
IRDM
Q1 26
Q4 25
-9.6%
35.3%
Q3 25
0.6%
34.9%
Q2 25
-21.6%
50.2%
Q1 25
-36.0%
17.0%
Q4 24
-22.1%
37.8%
Q3 24
-17.9%
47.0%
Q2 24
-34.6%
34.2%
Capex Intensity
AXSM
AXSM
IRDM
IRDM
Q1 26
13.7%
Q4 25
0.0%
15.7%
Q3 25
0.0%
9.5%
Q2 25
0.0%
9.5%
Q1 25
0.3%
11.4%
Q4 24
0.0%
11.4%
Q3 24
0.1%
8.7%
Q2 24
0.1%
6.2%
Cash Conversion
AXSM
AXSM
IRDM
IRDM
Q1 26
Q4 25
4.37×
Q3 25
2.71×
Q2 25
5.90×
Q1 25
2.01×
Q4 24
2.88×
Q3 24
4.85×
Q2 24
2.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXSM
AXSM

Segment breakdown not available.

IRDM
IRDM

Voice and data$57.4M26%
IoT data (2)$43.9M20%
Government$35.8M16%
Government service revenue (5)$26.8M12%
Subscriber equipment$23.1M11%
Hosted payload and other data service (4)$14.9M7%
Broadband (3)$12.9M6%
Commercial$1.6M1%

Related Comparisons